Related Experiment Video
Updated: Jul 21, 2026
09:14
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
11.0K
ANALYSIS OF THE QUALITY OF NATIONAL VACCINE AGAINST RUBELLA.
T N Unasova1, A S Binyatova1, O V Phadeykina1
1Scientific Center for Expert Evaluation of Medicinal Products.
Voprosy Virusologii
|December 10, 2022
Summary
High-quality rubella vaccines are crucial for disease elimination. A retrospective analysis of a domestic rubella vaccine demonstrated stable, high quality from 2012-2017, ensuring secure production technologies.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Rubella (German measles) was a widespread infection globally.
- Vaccination programs, including WHO's
Purpose of the Study:
- To conduct a retrospective quality analysis of a domestic rubella vaccine.
- To assess the vaccine's quality from 2012 to 2017.
Main Methods:
- Laboratory quality assessment of the domestic rubella vaccine.
- Retrospective analysis of quality control data from 2012-2017.
Main Results:
- The domestic rubella vaccine consistently met high-quality standards.
- Laboratory analyses indicated stable quality throughout the study period.
- The findings suggest secure and reliable production technologies.
Conclusions:
- The domestic rubella vaccine meets international quality standards.
- Consistent high quality supports ongoing rubella elimination efforts.
- The vaccine's production technology is secure and effective.
